IgG antibodies are commonly used in cancer treatment. They help the body's immune system fight cancer and are being ...

Navrogen, Inc. has announced groundbreaking advancements in monoclonal antibody (mAb) and antibody-drug conjugate (ADC) ...

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...

TIGIT in particular has proved to be a tricky target for drug developers, and BeiGene's decision comes just a few months after MSD abandoned the development of its anti-TIGIT antibody vibostolimab ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Blood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...

迈威生物 (688062.SH)，一家全产业链布局的创新型生物制药公司， 宣布将于当地时间 2025 年 4 月 25-30 日在美国芝加哥举行的 2025 年美国癌症研究协会 (AACR) 年会，以壁报形式公布 6 项研究成果 。

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.

Researchers at Yale Cancer Center have made a breakthrough finding that could lead to a therapies for glioblastoma and other ...

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced an upcoming presentation of preclinical data on the ...

目前，临床常用的 CA15-3 检测虽被 FDA 批准用于乳腺癌治疗反应监测和疾病复发监测，但在早期或局部乳腺癌检测中，其血清浓度并不总是升高，导致检测灵敏度较低，难以准确揪出早期 “隐藏” 的癌细胞。为了解决这一难题，来自澳大利亚的研究团队开展了一项研究，致力于寻找一种更精准的乳腺癌诊断方法。